Studies of mechanisms of niridazole‐elicited embryotoxicity: Evidence against a major role for covalent binding
- 1 January 1989
- journal article
- research article
- Published by Wiley in Teratology
- Vol. 39 (1) , 63-74
- https://doi.org/10.1002/tera.1420390108
Abstract
Studies reported here were designed to examine the hypothesis that covalent binding of reactive intermediates to macromolecules of the conceptus represents a major mechanism for the embryotoxicity of niridazole (NDZ). The roles of embryonic thiol content and oxygenation on: (1) malformation incidence; (2) reductive metabolism; and (3) covalent binding to embryonic macromolecules of metabolites resulting from reductive biotransformation of NDZ were studied. Results were compared with those from studies with the nondysmorphogenic analog of NDZ, 4′-methylniridazole (MNDZ). Day 10 rat embryos were pretreated for 5 hours in vitro with either L-buthionine-S, R-sulfoximine (BSO) or N-acetylcysteine (NAC) to modulate their glutathione (GSH) content. BSO reduced GSH levels, but NAC was ineffective. Following pretreatment, embryos were cultured for an additional 15 hours in the presence of [14C]NDZ or [14C]NDZ with an initial oxygen concentration of 5%. At the end of the culture period (day 11, AM), those embryos with active heartbeat and vitelline circulation were examined for asymmetric malformations. Drug metabolites were subjected to multiple extractions from the culture medium and subjected to quantitative high-performance liquid chromatography (HPLC) analysis. Homogenates of the embryos were extracted with trichloroacetic acid (TCA) to estimate the covalent binding of radiolabeled parent compound/metabolites. Autoradiographic analyses were performed on other embryos. BSO pretreatment, which reduces embryonic GSH tissue levels, dramatically increased both the conversion of NDZ to 1-thiocarbamoyl-2-imidazolidinone (TCI) (generated via reductive metabolism of NDZ) and covalently bound label but failed to increase embryotoxicity. NAC, by contrast, did not significantly affect embryonic GSH levels, TCI generation, or covalent binding. Because both rates of metabolism of NDZ to TCI and covalent binding could vary independently of malformation incidence, we concluded that they do not represent critical mechanistic factors for the embryotoxicity of NDZ and related nitroheterocycles.This publication has 36 references indexed in Scilit:
- Niridazole metabolism by rat embryos in vitroTeratology, 1988
- Differential glutathione depletion by l-buthionine-S, R-sulfoximine in rat embryo versus visceral yolk sac in vivo and in vitroBiochemical Pharmacology, 1986
- On the capacity of nitroheterocyclic compounds to elicit an unusual axial asymmetry in cultured rat embryosToxicology and Applied Pharmacology, 1986
- The effect of oxygen concentration on the teratogenicity of salicylate, niridazole, cyclophosphamide, and phosphoramide mustard in rat embryos in vitroTeratology, 1985
- The embryotoxicity of adriamycin in rat embryos in vitroToxicology and Applied Pharmacology, 1985
- No detectable reaction of the anion radical metabolite of nitrofurans with reduced glutathione or macromoleculesChemico-Biological Interactions, 1984
- Formation and identification of glutathione conjugates from 2-nitrosofluorene and N-hydroxy-2-aminofluoreneChemico-Biological Interactions, 1982
- Teratogenic bioactivation of cyclophosphamideLife Sciences, 1979
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Studies of the development of congenital anomalies in rats. III. Effects of inhibition of mitochondrial energy systems on embryonic developmentTeratology, 1975